Marinomed Biotech AG enters into license agreement with Procter & Gamble on Carragelose® products
Adhoc-Announcement
Marinomed Biotech AG signs financing agreement with Nice & Green S.A. to advance its scientific and clinical programs
Adhoc-Announcement
Marinomed Biotech AG shares positive clinical trial results for iota-carrageenan nasal spray in the prevention of COVID-19
Adhoc-Announcement
Marinomed Biotech AG: Carragelose® effective against SARS-CoV-2 in cell culture assays
Adhoc-Announcement
Stephanie Kniep, Dipl.-Ök.
Head of Investor Relations
Lucia Mayr-Harting, MSc
Public Relations